AG真人官方

Instil Bio (TIL) filed an 8-K (Item 8.01) reporting partner ImmuneOnco鈥檚 interim data from a Phase 2 open-label study of bispecific antibody IMM2510/AXN-2510 plus chemotherapy in first-line advanced non-small-cell lung cancer (NSCLC) patients in China.

By 1 Jul 2025, 33 patients had received 10 mg/kg; 21 were efficacy-evaluable. The overall partial response rate (PRR) was 62 %, with a pronounced signal in squamous NSCLC (80 %, 8/10) versus non-squamous (46 %, 5/11). Most patients had undergone only a single tumor assessment at the data cut-off, limiting durability insight.

Safety appeared acceptable: no dose-limiting toxicities, no treatment-related deaths or dose reductions, and just one discontinuation. Grade 鈮�3 treatment-related adverse events were mainly hematologic and infrequent; VEGF-linked and immune events were uncommon and generally low-grade.

The dataset will be presented at a future medical meeting. Though preliminary and based on a small cohort, the efficacy signal and tolerability profile are encouraging for 鈥�2510鈥檚 continued development and could strengthen Instil鈥檚 oncology pipeline prospects.

Air Industries Group (AIRI) filed a Form S-8 on 31 Jul 2025 to register 300,000 additional shares of common stock for issuance under its 2022 Equity Incentive Plan. The amendment, approved at the 2024 annual meeting, raises the plan鈥檚 share reserve from 350,000 to 650,000.

The company is classified as a non-accelerated filer and smaller reporting company. The filing automatically incorporates by reference AIRI鈥檚 2024 Form 10-K, Q1-25 Form 10-Q, numerous 2025 Form 8-Ks, and its 2025 definitive proxy, ensuring that all subsequent Exchange Act filings will also be deemed incorporated until the offering is completed or withdrawn.

Key exhibits include: (1) legal opinion from Ellenoff Grossman & Schole LLP, (2) the amended 2022 Equity Incentive Plan, (3) auditor consent from Marcum LLP, and (4) the Rule 457 filing-fee table. Part II outlines Nevada law鈥揵ased indemnification provisions for directors and officers and confirms the company carries D&O insurance. Standard undertakings commit AIRI to file post-effective amendments if material changes arise.

Air Industries Group (AIRI) filed a Form S-8 on 31 Jul 2025 to register 300,000 additional shares of common stock for issuance under its 2022 Equity Incentive Plan. The amendment, approved at the 2024 annual meeting, raises the plan鈥檚 share reserve from 350,000 to 650,000.

The company is classified as a non-accelerated filer and smaller reporting company. The filing automatically incorporates by reference AIRI鈥檚 2024 Form 10-K, Q1-25 Form 10-Q, numerous 2025 Form 8-Ks, and its 2025 definitive proxy, ensuring that all subsequent Exchange Act filings will also be deemed incorporated until the offering is completed or withdrawn.

Key exhibits include: (1) legal opinion from Ellenoff Grossman & Schole LLP, (2) the amended 2022 Equity Incentive Plan, (3) auditor consent from Marcum LLP, and (4) the Rule 457 filing-fee table. Part II outlines Nevada law鈥揵ased indemnification provisions for directors and officers and confirms the company carries D&O insurance. Standard undertakings commit AIRI to file post-effective amendments if material changes arise.

Compass, Inc. filed a Form D reporting completion of a $501,897 private placement of Class A common stock under Rule 506(b). The shares were issued on 16 Jul 2025 to a single investor in satisfaction of a hold-back obligation from a prior acquisition; therefore the transaction is tied to a business-combination settlement rather than a new cash raise.

The New York-based Delaware corporation is classified as operating in the Residential AG真人官方 Estate industry and discloses annual revenue of over $100 million. Minimum outside investment was $10,000; no non-accredited investors participated. No sales commissions or finder鈥檚 fees were paid, and the issuer does not expect the offering to continue beyond one year.

Given the company鈥檚 revenue scale, the 0.5 million-dollar issuance appears immaterial and enables Compass to conserve cash while meeting acquisition-related obligations with negligible dilution.

Shikiar Asset Management Inc. has filed a Schedule 13G revealing ownership of 152,700 FTAI Aviation Ltd. Series D Cumulative Perpetual Preferred Shares, representing 5.9 % of the class as of 30 June 2025. The New-York-based investment adviser reports sole voting and dispositive power over the entire stake, with no shared control. The filing is made under Rule 13d-1(b) because the firm qualifies as an Investment Adviser ("IA").

Crossing the 5 % threshold mandates this passive disclosure but does not signal an intent to influence company control; the certification expressly states the position is held in the ordinary course of business. While the preferred-share position does not affect common-stock governance, it adds another institutional holder to the preferred equity base, implying incremental demand for the income-oriented Series D shares.

Savers Value Village, Inc. (SVV) filed a Form 144 indicating that an insider intends to sell up to 600 common shares through Fidelity Brokerage Services on or after 22 Jul 2025. Based on the reference price in the notice, the stake is valued at $6,306. With 157,451,564 shares outstanding, the proposed sale equals roughly 0.0004 % of the float, implying negligible market impact.

The seller, identified in the three-month sales table as Richard Medway, has already disposed of 36,513 shares between May and July 2025 for gross proceeds of about $402 k. The 600 shares originate from a stock option granted 12 Jun 2019 and exercised for cash on the planned sale date.

This filing is routine compliance with Rule 144 for restricted/control securities. Given the de-minimis size relative to daily volume and market cap, the event is unlikely to influence valuation, though investors may note the ongoing insider selling trend.

Savers Value Village, Inc. (SVV) filed a Form 144 indicating that an insider intends to sell up to 600 common shares through Fidelity Brokerage Services on or after 22 Jul 2025. Based on the reference price in the notice, the stake is valued at $6,306. With 157,451,564 shares outstanding, the proposed sale equals roughly 0.0004 % of the float, implying negligible market impact.

The seller, identified in the three-month sales table as Richard Medway, has already disposed of 36,513 shares between May and July 2025 for gross proceeds of about $402 k. The 600 shares originate from a stock option granted 12 Jun 2019 and exercised for cash on the planned sale date.

This filing is routine compliance with Rule 144 for restricted/control securities. Given the de-minimis size relative to daily volume and market cap, the event is unlikely to influence valuation, though investors may note the ongoing insider selling trend.

FTAI Aviation has announced a significant change in its external auditor. The company's Audit Committee has appointed KPMG LLP as its new independent registered public accounting firm effective June 17, 2025, replacing Ernst & Young LLP (EY) who had served since 2016.

Key points from the transition:

• The change follows a comprehensive, competitive auditor selection process
• EY's dismissal was not due to any dissatisfaction with their services
• EY's reports for fiscal years 2023-2024 contained no adverse opinions or modifications
• No disagreements occurred between FTAI and EY on accounting principles, practices, or procedures
• No reportable events or prior consultations with KPMG on accounting matters

The Audit Committee Chair noted this change aligns with good corporate governance practices, particularly following FTAI's successful internalization and recent termination of their transition services agreement with their former manager.